Predictors of Recurrent Ductal Carcinoma In Situ after Breast-Conserving Surgery.
	    		
		   		
		   			
		   		
	    	
    	 
    	10.4048/jbc.2016.19.2.185
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Jung Yeon KIM
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Kyeongmee PARK
			        		
			        		;
		        		
		        		
		        		
			        		Guhyun KANG
			        		
			        		;
		        		
		        		
		        		
			        		Hyun Jung KIM
			        		
			        		;
		        		
		        		
		        		
			        		Geumhee GWAK
			        		
			        		;
		        		
		        		
		        		
			        		Young Joo SHIN
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Pathology, Inje University Sanggye Paik Hospital, Seoul, Korea. kpark@paik.ac.kr
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Original Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Breast;
			        		
			        		
			        		
				        		Carcinoma;
			        		
			        		
			        		
				        		Intraductal;
			        		
			        		
			        		
				        		Recurrence
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Breast;
				        		
			        		
				        		
					        		Carcinoma, Ductal*;
				        		
			        		
				        		
					        		Carcinoma, Intraductal, Noninfiltrating*;
				        		
			        		
				        		
					        		Cohort Studies;
				        		
			        		
				        		
					        		Diagnosis;
				        		
			        		
				        		
					        		Estrogens;
				        		
			        		
				        		
					        		Female;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Logistic Models;
				        		
			        		
				        		
					        		Mastectomy, Segmental*;
				        		
			        		
				        		
					        		Radiotherapy;
				        		
			        		
				        		
					        		Receptor, Epidermal Growth Factor;
				        		
			        		
				        		
					        		Receptors, Progesterone;
				        		
			        		
				        		
					        		Recurrence;
				        		
			        		
				        		
					        		Risk Factors
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:Journal of Breast Cancer
	            		
	            		 2016;19(2):185-190
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:English
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	PURPOSE: Local recurrence is a major concern in patients who have undergone surgery for ductal carcinoma in situ (DCIS). The present study assessed whether the expression levels of hormone receptors, human epidermal growth factor receptor 2 (HER2), and Ki-67, as well as resection margin status, tumor grade, age at diagnosis, and adjuvant hormonal therapy and radiotherapy (RT) are associated with recurrence in women with DCIS. METHODS: In total, 111 patients with DCIS were included in the present study. The invasive and noninvasive recurrence events were recorded. The clinicopathological features; resection margins; administration of hormonal therapy and RT; expression statuses of estrogen receptor (ER), progesterone receptor (PR), and HER2; Ki-67 expression; and molecular subtypes were evaluated. Logistic regression analysis was performed to examine the risk factors for recurrence. RESULTS: Recurrence was noted in 27 of 111 cases (24.3%). Involvement of resection margins, low tumor grade, high Ki-67 expression, and RT were independently associated with an increase in the recurrence rate (p<0.05, Pearson chi-square test). The recurrence rate was not significantly associated with patient age; ER, PR, and HER2 statuses; molecular subtype; and hormonal therapy. CONCLUSION: The results of the present study suggested that the involvement of resection margins, low tumor grade, high Ki-67 index, and the absence of adjuvant RT were independently associated with increased recurrence in patients with DCIS. Future studies should be conducted in a larger cohort of patients to further improve the identification of patients at high-risk for DCIS recurrence.